Patents Assigned to alphaGEN Co., Ltd.
  • Publication number: 20110289607
    Abstract: The present invention relates to a method for inhibiting expression of a target gene, which comprises introducing a cell, tissue, or individual organism with a double-stranded polynucleotide comprising DNA and RNA having a substantially identical nucleotide sequence with at least a partial nucleotide sequence of the target gene.
    Type: Application
    Filed: July 5, 2011
    Publication date: November 24, 2011
    Applicants: Kaoru SAIGO, ALPHAGEN CO., LTD.
    Inventors: Kumiko TEI, Takahide Kaji, Ryu Ueda, Kaoru Saigo
  • Publication number: 20080113351
    Abstract: The present invention provides a polynucleotide that not only has a high RNA interference effect on its target gene, but also has a very small risk of causing RNA interference against a gene unrelated to the target gene. A sequence segment conforming to the following rules (a) to (d) is searched from the base sequences of a target gene for RNA interference and, based on the search results, a polynucleotide capable of causing RNAi is designed, synthesized, etc.: (a) The 3? end base is adenine, thymine, or uracil, (b) The 5? end base is guanine or cytosine, (c) A 7-base sequence from the 3? end is rich in one or more types of bases selected from the group consisting of adenine, thymine, and uracil, and (d) The number of bases is within a range that allows RNA interference to occur without causing cytotoxicity.
    Type: Application
    Filed: November 13, 2006
    Publication date: May 15, 2008
    Applicant: alphaGEN Co., Ltd.
    Inventors: Yuki Naito, Masato Fujino, Shinobu Oguchi, Yukikazu Natori